Blog

Sharing Our Expertise

How to Stay Compliant in a Changing Pharma Regulatory Landscape
In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis...
Read More >
Understanding 505(b)(2) Drug Development & API Supply Issues
Situated between the NDA and the ANDA is an increasingly popular drug commercialization pathway – the...
Read More >
Behind the Scenes with LGM Pharma’s API Sourcing Team
Running a marathon is just like what we do here at LGM Pharma – and in more ways than one, as it turns...
Read More >
9 Key Sourcing Challenges for Small Pharma
Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of...
Read More >